1. Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE2/EP4 Signaling Pathway
   Mingjie Liang et al, 2023, Diabetes, Metabolic Syndrome and Obesity CrossRef
2. Liposomal quercetin: A promising strategy to combat hepatic insulin resistance and inflammation in type 2 diabetes mellitus
   Sónia Rocha et al, 2024, International Journal of Pharmaceutics CrossRef
3. A pilot study on the comparative evaluation of residual periodontal ligament in extracted teeth of chronic periodontitis patients with and without type 2 diabetes – Vital function of an occult dimension
   Irene Majo et al, 2023, Journal of Indian Society of Periodontology CrossRef
4. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases
   Derek Strassheim et al, 2021, Cells CrossRef
5. Deficiency of Group IVA Phospholipase A₂ in Collagen-Producing Cells Alleviates the Aggravated Hepatic Fibrosis in High-Fat Diet-Fed Mice after Returning to a Normal Diet
   Takeyoshi Ozaki et al, 2023, Biological and Pharmaceutical Bulletin CrossRef
6. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping Review
   Sofía Montemayor et al, 2023, Nutrients CrossRef
7. Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis
   You Lan et al, 2022, International Journal of Molecular Sciences CrossRef
8. Exploring Visceral and Subcutaneous Adipose Tissue Secretomes in Human Obesity: Implications for Metabolic Disease
   Darcy Kahn et al, 2022, Endocrinology CrossRef
9. Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy
   Zhenchao Liu et al, 2024, Frontiers in Endocrinology CrossRef
10. Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice
    Melinda H. Spooner et al, 2023, PLOS ONE CrossRef
11. Group IVA Phospholipase A₂ in Collagen-Producing Cells Promotes High-Fat Diet-Induced Infiltration of Inflammatory Cells into the Liver by Upregulating the Expression of MCP-1
    Saki Kishinaka et al, 2024, Biological and Pharmaceutical Bulletin CrossRef
12. Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics
    Yuping Zhou et al, 2023, Journal of Pharmaceutical Analysis CrossRef
13. Gut mycobiome in metabolic diseases: Mechanisms and clinical implication
    Xingyu Zhou et al, 2023, Biomedical Journal CrossRef
14. Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients—Randomized Control Trials (RCT)
    Dominika Maciejewska-Markiewicz et al, 2022, Nutrients CrossRef
15. Fatty Acid Oxidation and Pro-Resolving Lipid Mediators Are Related to Male Infertility
    Cinzia Signorini et al, 2022, Antioxidants CrossRef
16. Gαz-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice
    Rachel J Fenske et al, 2024, Journal of the Endocrine Society CrossRef
17. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease
    Hang Yin et al, 2022, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
18. Effect of dietary fats and soybean phospholipid on hepatic fatty acid metabolism in mice
    Takashi Ide, 2024, Food Science and Technology Research CrossRef
19. Analysis of the mechanism of action of quercetin in the treatment of hyperlipidemia based on metabolomics and intestinal flora
    Tongtong Wang et al, 2023, Food & Function CrossRef
20. Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
    Karen M. Wagner et al, 2021, Frontiers in Pharmacology CrossRef
21. IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
    Reza Elahi et al, 2024, Molecular Immunology CrossRef
22. Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ12,14PGJ2
    Ahmed Ayyash et al, 2022, Journal of Applied Toxicology CrossRef
23. 15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE2/EP4 in T2DM mice
    Weixuan Wang et al, 2023, Bioorganic Chemistry CrossRef
24. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE2–EP4 receptor–AKT signaling in a type 2 diabetes mellitus mouse model
    Mingjie Liang et al, 2023, Cellular Signalling CrossRef
25. Alterations in factors associated with diabetic retinopathy combined with thrombosis: A review
    Haiyan Wei et al, 2023, Medicine CrossRef